LATEST NEWS

Foley & Lardner partner J. Mark Waxman joins Institute Board
The proposed iMAP will reveal new targets for immunotherapy, and may lead to a new wave of medicines and vaccines that can prevent heart attacks and strokes; La Jolla Institute for Immunology researcher Klaus Ley and Scripps researcher Eric Topol are key members of the iMAP team.
Sometimes it takes a personal health crisis to galvanize people to pursue a life-changing path they could have never envisioned.
The finding is important to both the basic understanding of this disease—the world’s most common mosquito-borne illness—and to the hunt for an effective vaccine for dengue.
The Beacon optofluidic technology will be used to speed the identification of lifesaving treatments for deadly viruses including Ebola, Lassa and others.
Based on its history, HMCES could be the most important protein you've never heard of
Professors Shane Crotty, Ph.D., and Alessandro Sette, Dr. Biol.Sci., of La Jolla Institute for Immunology have been named as AAAS Fellows
This year’s list features four scientists at La Jolla Institute for Immunology
A new approach that targets young immune cells may also work for creating vaccines against the flu, dengue, malaria and hepatitis C
Seqster research portal empowers study participants to instantly collect & share medical records and genomic data with researchers
The award is given annually to a former Cancer Research Institute postdoctoral fellow in recognition of outstanding success in academia or industry for research that has had a major impact in the field of immunology.